Cargando…
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives
Co-expression of the epidermal growth factor receptor (EGFR, also known as ErbB1) and human epidermal growth factor receptor 2 (HER2) has been identified as a diagnostic or prognostic sign in various tumors. Despite the fact that lapatinib (EGFR/HER2 dual inhibitor) has shown to be successful, many...
Autores principales: | Elkamhawy, Ahmed, Son, Seohyun, Lee, Hwa Young, El-Maghrabey, Mahmoud H., Hamd, Mohamed A. El, Alshammari, Saud O., Abdelhameed, Abeer A., Alshammari, Qamar A., Abdeen, Ahmed, Ibrahim, Samah F., Mahdi, Wael A., Alshehri, Sultan, Alnajjar, Radwan, Choi, Won Jun, Al-Karmalawy, Ahmed A., Lee, Kyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862743/ https://www.ncbi.nlm.nih.gov/pubmed/36678540 http://dx.doi.org/10.3390/ph16010043 |
Ejemplares similares
-
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines
por: Son, Seohyun, et al.
Publicado: (2023) -
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations
por: Elkamhawy, Ahmed, et al.
Publicado: (2023) -
Two Versatile Pencil Graphite–Polymer Sensor Electrodes Coupled with Potentiometry and Potentiometric Titration Methods: Profiling Determinations of Vitamin V in Tablets and Urine Samples
por: Hassan, Abeer M. E., et al.
Publicado: (2022) -
Application of quality-by-design for adopting an environmentally green fluorogenic determination of benoxinate hydrochloride in eye drops and artificial aqueous humour
por: El Hamd, Mohamed A., et al.
Publicado: (2023) -
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
por: El-Kalyoubi, Samar, et al.
Publicado: (2023)